1. Startpage

Search

Current filters:


Use filters to refine the search results.

Start a new search
Results 1-10 of 38 (Search time: 0.007 seconds).
Item hits:
PreviewIssue dateOnline publication dateTitleAuthor(s)
59415.pdf.jpg201911-Nov-2019Cardiovascular risk categories in patients with nonalcoholic fatty liver disease and the role of low-density lipoprotein cholesterolLabenz, Christian; Prochaska, Jürgen H.; Huber, Yvonne; Nagel, Michael; Straub, Beate; Wild, Philipp; Galle, Peter R.; Schattenberg, Jörn
59893.pdf.jpg202030-Jun-2020Risk prediction in intrahepatic cholangiocarcinoma : direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC cancer staging systemHahn, Felix; Müller, Lukas; Mähringer-Kunz, Aline; Schotten, Sebastian; Düber, Christoph; Hinrichs, Jan B.; Maschke, Sabine K.; Galle, Peter R.; Bartsch, Fabian; Lang, Hauke; Weinmann, Arndt; Kloeckner, Roman
kaps_leonard-treatment_of_c-20210104145006284.pdf.jpg202020-Jan-2021Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection : a case reportKaps, Leonard; Labenz, Christian; Grimm, Daniel; Schwarting, Andreas; Galle, Peter R.; Schreiner, Oliver
diabetic_liver_injury_from_st-20220913193459567.pdf.jpg201314-Sep-2022Diabetic liver injury from streptozotocin is regulated through the caspase-8 homolog cFLIP involving activation of JNK2 and intrahepatic immunocompetent cellsKohl, Tobias; Gehrke, Nadine; Schad, Arno; Nagel, Michael; Wörns, Marcus-Alexander; Sprinzl, Martin; Zimmermann, Tim; He, You Wen; Galle, Peter R.; Schuchmann, Marcus; Schattenberg, Jörn
significant_liver_fibrosis_is-20221121132447370.pdf.jpg202230-Jan-2023Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIVMichel, Maurice; Wahl, Alisha; Anders, Malena; Alqahtani, Saleh A.; Kremer, Wolfgang M.; Galle, Peter R.; Labenz, Christian; Grimm, Daniel; Sprinzl, Martin; Schattenberg, Jörn M.
cost_evaluation_of_pageb_risk-20220630121855371.pdf.jpg202130-Jun-2022Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis BSprinzl, Martin F.; Feist, Christina; Koch, Sandra; Kremer, Wolfgang Maximilian; Lackner, Karl J.; Weinmann, Arndt; Galle, Peter R.
risk_factors_for_poorer_healt-20220111115107382.pdf.jpg202114-Jan-2022Risk factors for poorer health literacy in patients with liver cirrhosisKaps, Leonard; Hildebrand, Katharina; Nagel, Michael; Michel, Maurice; Kremer, Wolfgang Maximilian; Hilscher, Max; Galle, Peter R.; Schattenberg, Jörn M.; Wörns, Marcus-Alexander; Labenz, Christian
biology_and_significance_of_a-20220620120208132.pdf.jpg201920-Jun-2022Biology and significance of alpha-fetoprotein in hepatocellular carcinomaGalle, Peter R.; Foerster, Friedrich; Kudo, Masatoshi; Chan, Stephen L.; Llovet, Josep M.; Qin, Shukui; Schelman, William R.; Chintharlapalli, Sudhakar; Abada, Paolo B.; Sherman, Morris; Zhu, Andrew X.
irritable_bowel_syndrome_and_-20220925163838020.pdf.jpg201317-Oct-2022Irritable bowel syndrome and organic diseases : a comparative analysis of esophageal motilityThomaidis, Thomas; Götz, Martin; Gregor, Sebastian; Hoffman, Arthur; Kouroumalis, Elias; Möhler, Markus; Galle, Peter R.; Schwarting, Andreas; Kiesslich, Ralf
selective_internal_radiothera-20220914234950293.pdf.jpg20146-Oct-2022Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC) : study protocol for a randomized controlled trialKlöckner, Roman; Ruckes, Christian; Kronfeld, Kai; Wörns, Marcus-Alexander; Weinmann, Arndt; Galle, Peter R.; Lang, Hauke; Otto, Gerd; Eichhorn, Waltraud; Schreckenberger, Mathias; Düber, Christoph; Pitton, Michael B.

Refine search results